QUICKDRAW VENOUS CANE. Anvisa Registry n ° 80219050114. Models: QD22 and QD25. Lots under risk: 59091652, 59094887, 59222657, 59233637 and 59246684 (model QD22); 59085169, 59097289, 59352608 and 59437699 (model QD25). 의 안전성 경고

Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.

According to Edwards, the risks associated with specific product removal techniques are as follows: (1) The presence of scar tissue at the incision site can create resistance and increase the force required for removal of the cannula; (2) When the percutaneous technique is used, separation of the cannula may occur during removal if too much compression force is applied at the incision site (i.e. additional to the felt resistance if scar tissue is present).